USANA Health Sciences, Inc.

NYSE:USNA Voorraadrapport

Marktkapitalisatie: US$710.5m

USANA Health Sciences Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

USANA Health Sciences heeft een totaal eigen vermogen van $533.1M en een totale schuld van $0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk $671.3M en $138.2M. De EBIT USANA Health Sciences is $82.3M waardoor de rentedekking -7.4 is. Het heeft contanten en kortetermijnbeleggingen van $364.9M.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

US$0

Schuld

Rente dekkingsratio-7.4x
ContantUS$364.89m
AandelenUS$533.09m
Totaal verplichtingenUS$138.22m
Totaal activaUS$671.31m

Recente financiële gezondheidsupdates

Recent updates

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Sep 26
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?

Sep 08
Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?

USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 26
USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding

Jul 17
There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding

USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively

May 29
USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively

USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 03
USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?

May 01
Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

Apr 04
USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Feb 08
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

Jan 06
Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation

Oct 23

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Sep 09
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

Jul 27
Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

USANA Earnings Preview: From China's Challenge To India's Promise

Jul 21

USANA Health Sciences says Brown will transition to CEO in July 2023

Feb 13

Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

Feb 02
Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates

Oct 25

Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Oct 18
Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Jul 22
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Jul 07
Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Jun 14
Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $451.2M ) USNA } overtreffen de korte termijn passiva ( $114.8M ).

Langlopende schulden: De kortetermijnactiva USNA ( $451.2M ) overtreffen de langetermijnschulden ( $23.4M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: USNA is schuldenvrij.

Schuld verminderen: USNA had 5 jaar geleden geen schulden.

Schuldendekking: USNA heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: USNA heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.


Balans


Ontdek gezonde bedrijven